Using organoids embedded in a novel immune organ-on-chip technology, the team observed that immune cells from lymphoma survivors treated with certain immunotherapies do not organize themselves into ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

Third Quarter Revenue Growth of 12%Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 MillionRepresenting Growth of 27% to 31% BELGRADE, MT / ACCESSWIRE / November 12, 2024 / Xtant ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; ...

In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

A research team from the University of Basel has succeeded in synthesizing simple, environmentally sensitive cells complete ...

Sidra Medicine, a member of Qatar Foundation, has launched a state-of-the-art cord blood banking service. This is the country ...

Attorney Dr. Joshua Weiser has published a book proposing guidelines for embryonic stem cell research regulation in the ...

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...